There are dermatologists who don’t have much training in vulvar dermatology, and a lot of gyns don’t get as much training” as ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Xerosis is the most common cause of pruritus without an accompanying rash, and it can be associated with inflammatory skin diseases including atopic dermatitis, systemic diseases such as ...

This is an inflammatory skin condition and often involves redness, itching, and the formation of blisters or rashes. Topical corticosteroids, and antihistamines may be used to manage symptoms.

Overview of PBC PBC is a chronic autoimmune disease in which inflammation of the liver's ... and prominent symptoms of PBC are fatigue and pruritus, with about half of newly diagnosed patients ...

Allergies to inhaled environmental allergens, also known as atopic dermatitis, are estimated to affect 10-15 percent of dogs. Affected dogs often experience seasonal itching and inflammation ...

ZORYVE is the first and only branded topical therapy for three major inflammatory dermatoses. ZORYVE is uniquely formulated as an emollient, water-based product without fragrances or penetration ...

ICP-332 is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders, including atopic dermatitis (AD), vitiligo, inflammatory ...